Arvinas, Inc.

ARVN

$9.31

-2.92%-$0.28

High—

Low—

52W High-35.8%

Rel. vol—

Interval

Range6.5h

Volume—SMA5SMA10

—

AI analysis

Arvinas, Inc. is showing mixed intraday momentum with consolidation near key moving averages and heightened sensitivity to liquidity shifts.

Upside confirmation strengthens on sustained reclaim above short-term trend anchors.
Breakdown risk rises if support fails with accelerating sell volume.
Relative strength versus sector peers remains neutral-to-slightly positive.

Latest indicator snapshot

Live technical and fundamental context, tuned for quick reads.

SMA5

$9.30

5-period simple moving average

SMA10

$9.28

10-period simple moving average

SMA20

$9.26

20-period simple moving average

SMA50

$9.24

50-period simple moving average

EMA5

$9.30

5-period exponential moving average

EMA10

$9.28

10-period exponential moving average

EMA20

$9.27

20-period exponential moving average

DEMA20

$9.29

Double exponential moving average

Fibonacci

Retracement

Retracement levels

VWAP

$9.32

Volume weighted average price

MACD

0.016

Signal 0.010

RSI(14)

85.1

Relative strength oscillator

OBV

7.59K

On-balance volume

StochRSI

85.1 / 85.1

Fast oscillator pair

BBands Low

$9.21

Lower band

BBands Mid

$9.26

Middle band

BBands High

$9.31

Upper band

Market Cap

600.69M

Company size

P/E Ratio

37.24

Valuation multiple

EV / EBITDA

-1.62

Enterprise value multiple

ROE

1.6%

Return on equity

ROA

-1.0%

Return on assets

Operating Margin

66.4%

Operating efficiency

Net Margin

2.9%

Bottom-line profitability

Current Ratio

—

Short-term liquidity

Debt / Equity

—

Balance-sheet leverage

Dividend Yield

0.0%

Income yield

FCF Yield

—

Free cash flow yield

Beta

1.74

Market sensitivity

52W High

$14.51

52-week peak

52W Low

$6.97

52-week trough

Supply Chain of ARVN

Upstream / Downstream / Proxies

Upstream

Pfizer Inc. (Pfizer CentreOne / PC1)NYSE:PFEContract Manufacturing Organizations (CMOs) — Multiple Unnamed SuppliersContract Research Organizations (CROs) — Multiple Unnamed SuppliersSpecialty Chemical & Reagent SuppliersActive Pharmaceutical Ingredient (API) Intermediate Suppliers

Downstream

Pfizer Inc.NYSE:PFE Novartis AGNYSE:NVS Rigel Pharmaceuticals, Inc.NASDAQ:RIGL Genentech, Inc. (Roche Group)OTC:RHHBYBayer AGETR:BAYN

Proxies

Kymera Therapeutics, Inc.NASDAQ:KYMR Nurix Therapeutics, Inc.NASDAQ:NRIX C4 Therapeutics, Inc.NASDAQ:CCCC

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer